We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-10.49%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$149M
AUM Growth
-$24.6M
Cap. Flow
-$790K
Cap. Flow %
-0.53%
Top 10 Hldgs %
97.09%
Holding
66
New
13
Increased
8
Reduced
17
Closed
27

Top Buys

Rank Stock Value
1
GWAV icon
Greenwave Technology Solutions
GWAV
+$2.42M
2
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
+$836K
3
APVO icon
Aptevo Therapeutics
APVO
+$567K
4
RVPH
REVIVA PHARMA HLDGS INC
RVPH
+$539K
5
SONN
Sonnet BioTherapeutics
SONN
+$402K

Top Sells

Rank Stock Value
1
VANI icon
Vivani Medical
VANI
+$937K
2
TNXP icon
Tonix Pharmaceuticals
TNXP
+$911K
3
ELTK icon
Eltek
ELTK
+$778K
4
GMM icon
Global Mofy Metaverse
GMM
+$528K
5
RDHL
Redhill Biopharma
RDHL
+$434K

Sector Composition

Rank Sector Weight
1 Healthcare 3.47%
2 Industrials 0.4%
3 Technology 0.27%
4 Materials 0.15%
5 Financials 0.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$59.5M 40.04%
1,094
-60
-5% -$31.4K
OEF icon
2
PUT
iShares S&P 100 ETF
OEF
$19.8B
$50.9M 34.26%
2,511
-66
-3% -$16.5K
SPY icon
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$16.5M 11.13%
304
-196
-39% -$103K
OEF icon
4
CALL
iShares S&P 100 ETF
OEF
$19.8B
$5.96M 4.01%
294
-456
-61% -$114K
CORZ icon
5
PUT
Core Scientific
CORZ
$7.23B
$5.49M 3.69%
+5,908
New +$30.2K
VANI icon
6
Vivani Medical
VANI
$110M
$2.68M 1.8%
2,126,176
-546,842
-20% -$937K
BTBT icon
7
PUT
Bit Digital
BTBT
$484M
$1.37M 0.92%
4,308
+2,674
+164% +$6.53K
CORZW icon
8
Core Scientific Inc Tranche 1 Warrants
CORZW
$1.57B
$762K 0.51%
+168,974
New +$343K
CKPT
9
PUT
DELISTED
Checkpoint Therapeutics
CKPT
$582K 0.39%
2,708
+335
+14% +$596
RDHL
10
Redhill Biopharma
RDHL
$3.85M
$497K 0.33%
53,648
-39,122
-42% -$434K
CORZ icon
11
CALL
Core Scientific
CORZ
$7.23B
$459K 0.31%
+494
New +$2.52K
GWAV icon
12
Greenwave Technology Solutions
GWAV
$2.18M
$406K 0.27%
+2,086
New +$2.42M
ELTK icon
13
Eltek
ELTK
$60.1M
$396K 0.27%
40,565
-72,435
-64% -$778K
IWM icon
14
iShares Russell 2000 ETF
IWM
$80.9B
$304K 0.2%
+1,500
New +$303K
RVPH
15
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$303K 0.2%
+11,850
New +$539K
BIVI icon
16
BioVie
BIVI
$10.3M
$294K 0.2%
7,331
+440
+6% +$21.1K
LIPO
17
DELISTED
Lipella Pharmaceuticals
LIPO
$243K 0.16%
67,531
+36,294
+116% +$198K
SONN
18
DELISTED
Sonnet BioTherapeutics
SONN
$223K 0.15%
+29,799
New +$402K
SIDU icon
19
Sidus Space
SIDU
$180M
$194K 0.13%
83,100
– –
ENSC icon
20
Ensysce Biosciences
ENSC
$4.02M
$159K 0.11%
20,957
+5,587
+36% +$50.9K
APVO icon
21
Aptevo Therapeutics
APVO
$5.47M
$153K 0.1%
+38
New +$567K
GEVO icon
22
Gevo
GEVO
$397M
$139K 0.09%
250,000
-100,000
-29% -$67K
NEXI
23
DELISTED
NexImmune, Inc. Common Stock
NEXI
$138K 0.09%
49,904
-9,947
-17% -$33.5K
ATXI
24
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$131K 0.09%
37,394
+28,448
+318% +$165K
NRXP icon
25
PUT
NRX Pharmaceuticals
NRXP
$161M
$129K 0.09%
+530
New +$1.89K
1
2 3

Similar funds

NA
Novus Advisors Greenville, South Carolina $44.7M AUM 18.41% 1-Year Est. Return
CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Sabby Management's Q2 2024 Portfolio in Review

As of Q2 2024, Sabby Management held 66 positions worth $149M, down 14% from $173M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Sabby Management's Q2 2024 filing shows 13 new, 8 increased, 17 reduced and 27 closed positions. Its largest new stake was Greenwave Technology Solutions: 2,086 shares worth $406K. The largest sale was Vivani Medical, an estimated $937K.

By sector, the portfolio is most concentrated in Healthcare at 3.5% of assets, down from 5.6% a quarter earlier, followed by Industrials and Technology.

  • Sabby Management's largest Q2 2024 buy was Greenwave Technology Solutions: 2,086 shares worth $406K.
  • Sabby Management added most to Lipella Pharmaceuticals in Q2 2024, an estimated $198K increase.
  • Sabby Management's biggest Q2 2024 reduction was Vivani Medical, cutting an estimated $937K.
  • Sabby Management fully exited Tonix Pharmaceuticals in Q2 2024, selling an estimated $911K.
  • Sabby Management's ten largest holdings make up 97% of its $149M portfolio in Q2 2024.
  • Sabby Management opened 13 new positions and closed 27 in Q2 2024.
  • Sabby Management's portfolio value fell 14% quarter-over-quarter to $149M.

Based on Sabby Management's 13F filing for Q2 2024, filed 14 Aug 2024.